Cargando…
Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration
Several prediction models for progression of age-related macular degeneration (AMD) have been developed, but the added value of using genetic information in those models in addition to clinical characteristics is ambiguous. In this prospective cohort study, we explored the added value of genetics us...
Autores principales: | Heesterbeek, Thomas J., de Jong, Eiko K., Acar, Ilhan E., Groenewoud, Joannes M. M., Liefers, Bart, Sánchez, Clara I., Peto, Tunde, Hoyng, Carel B., Pauleikhoff, Daniel, Hense, Hans W., den Hollander, Anneke I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488669/ https://www.ncbi.nlm.nih.gov/pubmed/31036867 http://dx.doi.org/10.1038/s41598-019-43144-3 |
Ejemplares similares
-
Geographic distribution of rare variants associated with age-related macular degeneration
por: Geerlings, Maartje J., et al.
Publicado: (2018) -
Risk factors for progression of age‐related macular degeneration
por: Heesterbeek, Thomas J, et al.
Publicado: (2020) -
A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo
por: Paun, Constantin C., et al.
Publicado: (2016) -
Genetic Risk in Families with Age-Related Macular Degeneration
por: de Breuk, Anita, et al.
Publicado: (2021) -
Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway
por: Kersten, Eveline, et al.
Publicado: (2019)